OPINION: Healthcare is getting more expensive, let’s not make it worse by letting big pharma run rampant

Marlon Banner
Marlon Banner
0Comments

As healthcare costs continue to rise, working Americans are running out of patience. Across the U.S. families are watching their premiums and out-of-pocket costs climb faster than their paychecks. While politicians in Washington fight over who’s to blame, Big Pharma still enjoys record profits.

In Oklahoma, more than 300,000 people who rely on marketplace insurance are now facing major premium hikes. It’s a snapshot of a national crisis—as inflation raises prices on everything from gas to groceries, healthcare is becoming the most painful bill of all.

Pharmaceutical companies like to claim that high prices are justified by “innovation” and research costs, but that argument doesn’t hold up. The same corporations spending billions on TV ads, political lobbying, and lavish executive salaries want us to believe that a $500 prescription bottle is the cost for the medicine. The truth is Big Pharma’s marketing budgets often exceed what they spend on research and development.

For years, drugmakers have used their money and influence to dominate Washington. They’ve poured hundreds of millions of dollars into lobbying both parties to make sure any real reform dies before it reaches Congress. When politicians need campaign cash, the pharmaceutical industry is happy to supply it, as long as lawmakers look the other way on price hikes.

That’s how we’ve ended up here—a health care system designed to enrich the most powerful players while punishing the rest. Every year, drug prices climb faster than wages. Every year, more Americans skip medications, split doses, and delay treatments. Every year, the same corporations release new medications that cost more than a month’s rent.

It doesn’t have to be this way. There are already tools that help rein in costs like pharmacy benefit managers, which negotiate prices down on behalf of employers and insurers. But Big Pharma is lobbying hard to weaken those negotiators and push “reform” bills that ban the remaining practices working to keep prices in check. We’ve seen states like Arkansas pass similar legislation that raised drug costs and disrupted care for seniors and working families. Now, similar proposals are appearing in legislatures across the country, often written with the help of drug company lobbyists.

If lawmakers want to prove they’re serious about affordability, here’s where to start:

  • Stop taking cues from Big Pharma’s lobbyists.
  • Block any bill that would increase premiums, copays, or prescription costs for working Americans.
  • Demand transparency from drug manufacturers, not the middlemen already trying to keep prices down.

The next election should be a referendum on affordability. Voters should demand that every candidate, regardless of party, pledge not to sign a single law that raises health care costs. No more gimmicks, no more “transparency” schemes that benefit corporations, and no more pretending that the people driving prices up are the ones fixing the problem.

For decades, the pharmaceutical industry has treated America’s health care system like a slot machine, and they always win. It’s time for Washington to stop letting them pull the lever.

Banner is an Oklahoma Political Activist with years of experience at the state and national level.



Related

Jim Jones Deputy Commissioner for Human Foods of FDA - Official Website

Cities located in Rogers County saw FDA inspections of 4 companies in Q3

There were four companies in a city associated with Rogers County that received four FDA inspections in the third quarter of 2025, according to the U.S. Food and Drug Administration.

Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA - Official Website

How many companies in cities across Osage County received FDA citations in Q3?

There was one company in a city associated with Osage County that received an FDA citation as a result of one inspection conducted in the county over the third quarter of 2025, according to reports from the U.S. Food and Drug Administration (FDA).

Suzanne Roosen Acting Director of the Office of Food Policy and Response (OFPR)

How many companies in cities across Wagoner County received FDA citations in Q3?

There was one company in a city associated with Wagoner County that received an FDA citation as a result of one inspection conducted in the county over the third quarter of 2025, according to reports from the U.S. Food and Drug Administration (FDA).

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Tulsa Standard.